Prof. Jacques Morel on risk factors of serious infections in patients with RA treated with tocilizumab

from The Rheumatology Podcast · host Oxford University Press

Professor Jaap van Laar interviews Prof. Jacques Morel, University of Montpellier, regarding his study on risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab.

Episode metadata supplied by the publisher feed · Published Apr 18, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Prof. Jacques Morel on risk factors of serious infections in patients with RA treated with tocilizumab

0:00 6:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Rheumatology Podcast?

This episode is 6 minutes long.

When was this The Rheumatology Podcast episode published?

This episode was published on April 18, 2018.

Can I download this The Rheumatology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!